Join our expert panel for discussions on:
- Mechanisms of fibrosis in different organs and common pathways
- Treatments for fibrosis in other organs systems
- Assessment and clinical management of fibrostenotic disease in patients with IBD
- Developing new imaging, biomarker, and clinical endpoints for drug development
- Exploring the pipeline of drug development for fibrostenosis in IBD
Followed by a panel discussion and Q & A led by Iris Dotan, MD, Director, Division of Gastroenterology.
Join Us Tuesday, January 19, 2021 at 1 p.m. EST To learn more about our solutions, please visit Alimentiv.com